LSD1: biologic roles and therapeutic targeting
- PMID: 27479862
- PMCID: PMC5066116
- DOI: 10.2217/epi-2016-0009
LSD1: biologic roles and therapeutic targeting
Abstract
LSD1 (KDM1A; BHC110; AOF2) was the first protein reported to exhibit histone demethylase activity and has since been shown to have multiple essential roles in mammalian biology. Given its enzymatic activity and its high-level expression in many human malignancies, a significant recent focus has been the development of pharmacologic inhibitors. Here we summarize structural and biochemical knowledge of this important epigenetic regulator, with a particular emphasis on the functional and preclinical studies in oncology that have provided justification for the evaluation of tranylcypromine derivative LSD1 inhibitors in early phase clinical trials.
Keywords: GSK2879552; LSD1; ORY1001; acute myeloid leukemia; histone demethylase; small-cell lung cancer.
Conflict of interest statement
Financial & competing interests disclosure A Maiques-Diaz and T Somervaille are supported by Cancer Research UK Grant Number C5759/A12328. T Somervaille has ongoing research collaborations with Oryzon Genomics and consults for Imago Biosciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Figures


References
-
- Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693–705. - PubMed
-
- Højfeldt JW, Agger K, Helin K. Histone lysine demethylases as targets for anticancer therapy. Nat. Rev. Drug Discov. 2013;12(12):917–930. - PubMed
-
- Shi YY, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119(7):941–953. - PubMed
-
•• Identifies LSD1 as a histone demethylase.
-
- Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature. 1998;395(6705):917–921. - PubMed
-
• Identifies LSD1 as part of a deacetylation complex.
-
- Humphrey GW, Wang Y, Russanova VR, et al. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 2001;276(9):6817–6824. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical